De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Vimta Labs Beheer

Beheer criteriumcontroles 3/4

De CEO Vimta Labs' is Harita Vasireddi, benoemd in Jul2013, heeft een ambtstermijn van 11.25 jaar. De totale jaarlijkse vergoeding van { bedraagt ₹ 13.44M, bestaande uit 100% salaris en 0% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.76% van de aandelen van het bedrijf, ter waarde ₹ 89.87M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.1 jaar en 6.1 jaar.

Belangrijke informatie

Harita Vasireddi

Algemeen directeur

₹13.4m

Totale compensatie

Percentage CEO-salaris	100.0%
Dienstverband CEO	11.3yrs
Eigendom CEO	0.8%
Management gemiddelde ambtstermijn	5.1yrs
Gemiddelde ambtstermijn bestuur	6.1yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Harita Vasireddi's beloning veranderd ten opzichte van Vimta Labs's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	n/a	n/a	₹411m
Mar 31 2024	₹13m	₹13m	₹410m
Dec 31 2023	n/a	n/a	₹413m
Sep 30 2023	n/a	n/a	₹415m
Jun 30 2023	n/a	n/a	₹483m
Mar 31 2023	₹16m	₹13m	₹482m
Dec 31 2022	n/a	n/a	₹473m
Sep 30 2022	n/a	n/a	₹488m
Jun 30 2022	n/a	n/a	₹453m
Mar 31 2022	₹18m	₹15m	₹413m
Dec 31 2021	n/a	n/a	₹372m
Sep 30 2021	n/a	n/a	₹336m
Jun 30 2021	n/a	n/a	₹314m
Mar 31 2021	₹7m	₹7m	₹214m
Dec 31 2020	n/a	n/a	₹137m
Sep 30 2020	n/a	n/a	₹104m
Jun 30 2020	n/a	n/a	₹37m
Mar 31 2020	₹13m	₹13m	₹68m
Dec 31 2019	n/a	n/a	₹136m
Sep 30 2019	n/a	n/a	₹140m
Jun 30 2019	n/a	n/a	₹200m
Mar 31 2019	₹12m	₹12m	₹253m
Dec 31 2018	n/a	n/a	₹236m
Sep 30 2018	n/a	n/a	₹245m
Jun 30 2018	n/a	n/a	₹218m
Mar 31 2018	₹941k	₹941k	₹164m

Compensatie versus markt: De totale vergoeding ($USD 160.34K ) Harita } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.95K ).

Compensatie versus inkomsten: De vergoeding van Harita is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Harita Vasireddi (50 yo)

11.3yrs

Tenure

₹13,440,000

Compensatie

Ms. Harita Vasireddi, B. Pharm, MBA (USA) has been the Managing Director of Vimta Labs Ltd. since July 15, 2013 and serves as its Whole Time Director. She serves as an Independent Director of Avantel Limit...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Sivalinga Vasireddi	Executive Chairman	19.5yrs	₹15.12m	11.72% ₹ 1.4b
Harita Vasireddi	MD & Whole Time Director	11.3yrs	₹13.44m	0.76% ₹ 89.9m
D. R. Naidu	Chief Financial Officer	3.7yrs	₹4.63m	geen gegevens
V. Vungal	Executive Director of Operations & Executive Director	11.3yrs	₹13.44m	8.02% ₹ 951.3m
Sujani Vasireddi	Company Secretary & Compliance Officer	6.2yrs	₹3.17m	geen gegevens
Satya Neerukonda	Executive Director	no data	₹13.44m	geen gegevens
Suresh Kumar	President	5.1yrs	geen gegevens	0.014% ₹ 1.6m
Upendra Bhatnagar	Senior Vice President of Preclinical	2.2yrs	geen gegevens	geen gegevens

5.1yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 524394 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Sivalinga Vasireddi	Executive Chairman	19.5yrs	₹15.12m	11.72% ₹ 1.4b
Harita Vasireddi	MD & Whole Time Director	19.5yrs	₹13.44m	0.76% ₹ 89.9m
V. Vungal	Executive Director of Operations & Executive Director	33.9yrs	₹13.44m	8.02% ₹ 951.3m
Satya Neerukonda	Executive Director	5.3yrs	₹13.44m	geen gegevens
Kanury Rao	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Pankaj Shah	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Yalamanchili Rani	Independent Non-Executive Director	6.8yrs	₹280.00k	geen gegevens
Gutta Rao	Independent Non-Executive Director	5.4yrs	₹280.00k	geen gegevens
Sanjay Dave	Independent Non-Executive Director	5.4yrs	₹280.00k	geen gegevens
Yadagiri Pendri	Independent Non-Executive Director	4.2yrs	geen gegevens	geen gegevens

6.1yrs

Gemiddelde duur

68.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 524394 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.1 jaar).

Vimta Labs Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Insider recently sold ₹3.5m worth of stock

Vimta Labs Limited, Annual General Meeting, Jul 18, 2024

President recently sold ₹982k worth of stock

Insider recently sold ₹4.9m worth of stock

President recently sold ₹2.3m worth of stock

Insufficient new directors

Recent updates

New minor risk - Insider selling

Investor sentiment improves as stock rises 17%

Vimta Labs Limited Approves Dividend for the Year Ended March 31, 2024

Vimta Labs Limited to Report Q1, 2025 Results on Jul 17, 2024

Upcoming dividend of ₹2.00 per share

Insider recently sold ₹3.5m worth of stock

Full year 2024 earnings released: EPS: ₹18.51 (vs ₹21.77 in FY 2023)

Vimta Labs Limited, Annual General Meeting, Jul 18, 2024

Full year 2024 earnings released: EPS: ₹18.51 (vs ₹21.77 in FY 2023)

Investor sentiment improves as stock rises 23%

Investor sentiment deteriorates as stock falls 15%

President recently sold ₹982k worth of stock

Third quarter 2024 earnings released: EPS: ₹4.57 (vs ₹4.62 in 3Q 2023)

Vimta Labs Limited to Report Q3, 2024 Results on Jan 31, 2024

Second quarter 2024 earnings released: EPS: ₹2.85 (vs ₹5.97 in 2Q 2023)

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 17%

Insider recently sold ₹4.9m worth of stock

First quarter 2024 earnings released: EPS: ₹5.51 (vs ₹5.45 in 1Q 2023)

Investor sentiment improves as stock rises 19%

Vimta Labs Limited Declares Dividend for the Financial Year Ended March 31, 2023

Upcoming dividend of ₹2.00 per share at 0.5% yield

Vimta Labs Limited to Report Q4, 2024 Results on May 30, 2024

Full year 2023 earnings released: EPS: ₹21.77 (vs ₹18.70 in FY 2022)

Vimta Labs Limited Recommends Dividend for the Financial Year 2022-2023

Investor sentiment deteriorates as stock falls 16%

Third quarter 2023 earnings released: EPS: ₹4.62 (vs ₹5.28 in 3Q 2022)

President recently sold ₹2.3m worth of stock

Insufficient new directors

Investor sentiment improved over the past week

Insider recently sold ₹16m worth of stock

Insufficient new directors

First quarter 2023 earnings released: EPS: ₹5.45 (vs ₹3.65 in 1Q 2022)

Investor sentiment improved over the past week

Upcoming dividend of ₹2.00 per share

Vimta Labs Limited Recommends Dividend for the Financial Year Ended March 31, 2022

Full year 2022 earnings released: EPS: ₹18.70 (vs ₹9.68 in FY 2021)

Vimta Labs Limited Recommends Dividend for the Year 2021-2022

Vimta Labs Limited, Annual General Meeting, Jun 25, 2022

Vimta Labs Limited to Report Q4, 2022 Results on May 12, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹4.41 (vs ₹3.41 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹3.65 (vs ₹0.88 loss in 1Q 2021)

Investor sentiment improved over the past week

Upcoming dividend of ₹2.00 per share

Full year 2021 earnings released: EPS ₹9.68 (vs ₹3.10 in FY 2020)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹9.68 (vs ₹3.10 in FY 2020)

Vimta Labs Limited Recommends Dividend for the Year 2020-2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day low: ₹160

Chief Financial Officer has left the company

Vimta Labs Limited Announces Executive Changes

Vimta Labs Limited to Report Q3, 2021 Results on Jan 23, 2021

Market bids up stock over the past week

New 90-day high: ₹147

First half earnings released

New 90-day high: ₹139

Vimta Labs Limited Recommends No Dividend for the Year 2019-2020

First quarter earnings released

New 90-day high - ₹98.50

Analyse CEO-vergoeding

CEO

Tenure